These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
343 related articles for article (PubMed ID: 25623765)
1. [Prognostic value of blood neutrophil-to-lymphocyte ratio (NLR) and platelet-to-lymphocyte ratio (PLR) in patients with gastric cancer]. Li S; Xu X; Liang D; Tian G; Song S; He Y Zhonghua Zhong Liu Za Zhi; 2014 Dec; 36(12):910-5. PubMed ID: 25623765 [TBL] [Abstract][Full Text] [Related]
2. Increased Neutrophil-Lymphocyte Ratio Is a Poor Prognostic Factor in Patients with Esophageal Cancer in a High Incidence Area in China. Yutong H; Xiaoli X; Shumei L; Shan S; Di L; Baoen S Arch Med Res; 2015 Oct; 46(7):557-63. PubMed ID: 26385485 [TBL] [Abstract][Full Text] [Related]
3. Preoperative neutrophil-to-lymphocyte ratio plus platelet-to-lymphocyte ratio in predicting survival for patients with stage I-II gastric cancer. Sun X; Liu X; Liu J; Chen S; Xu D; Li W; Zhan Y; Li Y; Chen Y; Zhou Z Chin J Cancer; 2016 Jun; 35(1):57. PubMed ID: 27342313 [TBL] [Abstract][Full Text] [Related]
4. Application of platelet/lymphocyte and neutrophil/lymphocyte ratios in early diagnosis and prognostic prediction in patients with resectable gastric cancer. Lian L; Xia YY; Zhou C; Shen XM; Li XL; Han SG; Zheng Y; Mao ZQ; Gong FR; Wu MY; Chen K; Tao M; Li W Cancer Biomark; 2015; 15(6):899-907. PubMed ID: 26444485 [TBL] [Abstract][Full Text] [Related]
5. Prognostic significance of preoperative neutrophil/lymphocyte ratio and platelet/lymphocyte ratio in patients with gallbladder carcinoma. Zhang Y; Jiang C; Li J; Sun J; Qu X Clin Transl Oncol; 2015 Oct; 17(10):810-8. PubMed ID: 26077119 [TBL] [Abstract][Full Text] [Related]
6. Prognostic significance of the neutrophil-to-lymphocyte and platelet-to-lymphocyte ratio in patients with metastatic gastric cancer. Zhao G; Liu N; Wang S; Guo J; Song X; Qi Y; Qiu W; Lv J Medicine (Baltimore); 2020 Mar; 99(10):e19405. PubMed ID: 32150090 [TBL] [Abstract][Full Text] [Related]
7. The prognostic significance of the neutrophil-to-lymphocyte ratio and the platelet-to-lymphocyte ratio in giant cell tumor of the extremities. Chen Z; Zhao G; Chen F; Xia J; Jiang L BMC Cancer; 2019 Apr; 19(1):329. PubMed ID: 30961549 [TBL] [Abstract][Full Text] [Related]
8. Are neutrophil/lymphocyte ratio and platelet/lymphocyte ratio associated with prognosis in patients with HER2-positive early breast cancer receiving adjuvant trastuzumab? Ulas A; Avci N; Kos T; Cubukcu E; Olmez OF; Bulut N; Degirmenci M J BUON; 2015; 20(3):714-22. PubMed ID: 26214622 [TBL] [Abstract][Full Text] [Related]
9. Are pretreatment neutrophil-lymphocyte ratio and platelet-lymphocyte ratio useful in predicting the outcomes of patients with small-cell lung cancer? Deng M; Ma X; Liang X; Zhu C; Wang M Oncotarget; 2017 Jun; 8(23):37200-37207. PubMed ID: 28380461 [TBL] [Abstract][Full Text] [Related]
10. Prognostic value of neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio in gastric cancer. Zhang Y; Lu JJ; Du YP; Feng CX; Wang LQ; Chen MB Medicine (Baltimore); 2018 Mar; 97(12):e0144. PubMed ID: 29561419 [TBL] [Abstract][Full Text] [Related]
11. Can the neutrophil-lymphocyte ratio and platelet-lymphocyte ratio be beneficial in predicting lymph node metastasis and promising prognostic markers of gastric cancer patients? Tumor maker retrospective study. Zhang LX; Wei ZJ; Xu AM; Zang JH Int J Surg; 2018 Aug; 56():320-327. PubMed ID: 29969732 [TBL] [Abstract][Full Text] [Related]
12. The Platelet-to-Lymphocyte Ratio Versus Neutrophil-to-Lymphocyte Ratio: Which is Better as a Prognostic Factor in Gastric Cancer? Kim EY; Lee JW; Yoo HM; Park CH; Song KY Ann Surg Oncol; 2015 Dec; 22(13):4363-70. PubMed ID: 25805235 [TBL] [Abstract][Full Text] [Related]
13. Preoperative Neutrophil Lymphocyte Ratio and Platelet Lymphocyte Ratio Cannot Predict Lymph Node Metastasis and Prognosis in Patients with Early Gastric Cancer: a Single Institution Investigation in China. Zhu GS; Tian SB; Wang H; Ma MG; Liu Y; Du HS; Long YP Curr Med Sci; 2018 Feb; 38(1):78-84. PubMed ID: 30074155 [TBL] [Abstract][Full Text] [Related]
14. Prognostic significance of neutrophil lymphocyte ratio and platelet lymphocyte ratio in advanced gastric cancer patients treated with FOLFOX chemotherapy. Lee S; Oh SY; Kim SH; Lee JH; Kim MC; Kim KH; Kim HJ BMC Cancer; 2013 Jul; 13():350. PubMed ID: 23876227 [TBL] [Abstract][Full Text] [Related]
15. Combined neutrophil/platelet/lymphocyte/differentiation score predicts chemosensitivity in advanced gastric cancer. Huang Z; Liu Y; Yang C; Li X; Pan C; Rao J; Li N; Liao W; Lin L BMC Cancer; 2018 May; 18(1):515. PubMed ID: 29720123 [TBL] [Abstract][Full Text] [Related]
16. [Effect of preoperative monocyte-lymphocyte ratio on prognosis of patients with resectable esophagogastric junction cancer]. Zhou WJ; Wu J; Li XD; Wang Q; Ni XF; Jiang JT; Ji M; Wu CP Zhonghua Zhong Liu Za Zhi; 2017 Mar; 39(3):178-183. PubMed ID: 28316215 [No Abstract] [Full Text] [Related]
17. Prognostic Value of Baseline Neutrophil-Lymphocyte and Platelet-Lymphocyte Ratios in Local and Advanced Gastric Cancer Patients. Aldemir MN; Turkeli M; Simsek M; Yildirim N; Bilen Y; Yetimoglu H; Bilici M; Tekin SB Asian Pac J Cancer Prev; 2015; 16(14):5933-7. PubMed ID: 26320475 [TBL] [Abstract][Full Text] [Related]
18. Prognostic effect of high pretreatment neutrophil to lymphocyte ratio on survival of patients with gastric adenocarcinoma in China. Qiu M; Zhou Y; Jin Y; Wei XL; Wang DS; Ren C; Bai L; Yang DJ; Xu RH Int J Biol Markers; 2015 Feb; 30(1):e96-103. PubMed ID: 25450650 [TBL] [Abstract][Full Text] [Related]
19. Prognostic significance of the neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio in patients with stage III and IV colorectal cancer. Kim JH; Lee JY; Kim HK; Lee JW; Jung SG; Jung K; Kim SE; Moon W; Park MI; Park SJ World J Gastroenterol; 2017 Jan; 23(3):505-515. PubMed ID: 28210087 [TBL] [Abstract][Full Text] [Related]
20. Combined neutrophil-lymphocyte ratio and platelet-lymphocyte ratio predicts chemotherapy response and prognosis in patients with advanced gastric cancer. Hirahara T; Arigami T; Yanagita S; Matsushita D; Uchikado Y; Kita Y; Mori S; Sasaki K; Omoto I; Kurahara H; Maemura K; Okubo K; Uenosono Y; Ishigami S; Natsugoe S BMC Cancer; 2019 Jul; 19(1):672. PubMed ID: 31286873 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]